How Visikol’s Liver Fibrosis Assay is Accelerating the Development of Therapeutics
Drug discovery is a complex process that involves identifying and developing new drugs to treat a wide range of [...]
Drug discovery is a complex process that involves identifying and developing new drugs to treat a wide range of [...]
Name: Jonathan Linneman Institutions: PhD/MS in Biology from Georgia State University BA in Psychology from Mercer University [...]
Drug discovery and development is a complex and expensive process that involves the identification and optimization of compounds that [...]
Cell culture is a powerful and versatile technique that enables researchers to explore the intricacies of cell biology, understand [...]
Here at Visikol, we recently announced the launch of our multiplex imaging services in a GLP setting (read more [...]
When developing a therapeutic, one of the critical questions that needs to be addressed is how the therapeutic will [...]
How can you maximize the potential of HUREL® Micro Livers in your drug discovery and development process? In this [...]
Name: Megan Casco, Ph.D. Institutions: Ph.D. in Bioengineering from Clemson University B.S. in Bioengineering with a materials concentration [...]
There is a race in the pharmaceutical industry that aims to treat neurological disorders, such as Alzheimer’s and Parkinson’s [...]
Over the last seven years, Visikol has continually been on the forefront of advanced tissue imaging technologies with [...]